1. Home
  2. VSAT vs EVO Comparison

VSAT vs EVO Comparison

Compare VSAT & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

VSAT

ViaSat Inc.

HOLD

Current Price

$44.68

Market Cap

6.2B

Sector

Technology

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$3.67

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VSAT
EVO
Founded
1986
1993
Country
United States
Germany
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.2B
1.1B
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
VSAT
EVO
Price
$44.68
$3.67
Analyst Decision
Buy
Strong Buy
Analyst Count
7
1
Target Price
$33.00
$7.00
AVG Volume (30 Days)
1.8M
68.7K
Earning Date
02-05-2026
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,582,796,000.00
$887,396,457.00
Revenue This Year
$5.25
N/A
Revenue Next Year
$3.45
$8.52
P/E Ratio
N/A
N/A
Revenue Growth
1.23
N/A
52 Week Low
$7.36
$2.84
52 Week High
$49.68
$4.80

Technical Indicators

Market Signals
Indicator
VSAT
EVO
Relative Strength Index (RSI) 58.36 56.52
Support Level $42.04 $3.53
Resistance Level $49.68 $3.81
Average True Range (ATR) 2.62 0.08
MACD 0.17 0.00
Stochastic Oscillator 53.09 54.17

Price Performance

Historical Comparison
VSAT
EVO

About VSAT ViaSat Inc.

Viasat Inc provides bandwidth technologies and services in three segments: communication services and defense and advanced technologies. The communication services segment provides a wide range of broadband and narrowband communications solutions across government and commercial mobility markets, as well as for residential and enterprise fixed broadband customers: and the defense and advanced technologies segment develops and offers a diverse array of resilient, vertically integrated solutions to government and commercial customers, leveraging core technical competencies in encryption, cyber security, tactical gateways, modems and waveforms. A large majority of the firm's revenue is generated from communication services segment.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: